Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,167 | 225 | -1,758 | -38,108 | -28,858 |
| Depreciation Amortization | 3,508 | 1,976 | 989 | 3,911 | 3,006 |
| Income taxes - deferred | -648 | 79 | -362 | -2,726 | -1,008 |
| Accounts receivable | -335 | -1,176 | 14 | 324 | -159 |
| Accounts payable and accrued liabilities | -876 | -913 | -469 | -1,643 | -310 |
| Other Working Capital | -1,664 | -3,585 | -3,329 | -3,959 | -4,532 |
| Other Operating Activity | -3,403 | -994 | 1,173 | 6,777 | 4,551 |
| Operating Cash Flow | $-4,585 | $-4,389 | $-3,741 | $-35,423 | $-27,309 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,598 | 7,598 | 4 | 30,992 | 20,992 |
| PPE Investments | -235 | -165 | -108 | -1,811 | -1,139 |
| Net Acquisitions | -4,002 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 248 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $13,609 | $7,433 | $-104 | $29,181 | $19,853 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,246 | 6 | N/A | 1,993 | 1,991 |
| Other Financing Activity | -1,438 | -18 | -18 | -169 | -67 |
| Financing Cash Flow | $808 | $-12 | $-18 | $1,824 | $1,924 |
| Exchange Rate Effect | 329 | 152 | -172 | 836 | 567 |
| Beginning Cash Position | 15,814 | 15,814 | 15,814 | 19,397 | 19,397 |
| End Cash Position | 25,974 | 18,999 | 11,779 | 15,814 | 14,432 |
| Net Cash Flow | $10,160 | $3,184 | $-4,035 | $-3,583 | $-4,965 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,585 | -4,389 | -3,741 | -35,423 | -27,309 |
| Capital Expenditure | -235 | -165 | -108 | -1,811 | -1,139 |
| Free Cash Flow | -4,821 | -4,554 | -3,849 | -37,234 | -28,448 |